complex t2 dm patients with multiple comorbidities safety considerations for dpp 4 inhibitors

Report

Post on 31-Dec-2015

15 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

- PowerPoint PPT Presentation

TRANSCRIPT

top related

janos fischer-serendipitous target-based drug discovery ·...
Documents
2018 annual trend report · 2020-04-30 · focus on...
Documents
2018 annual trend report...as predicted in our 2016 trend...
Documents
dpp-4 inhibitors: ‘gliptins’ - flame · 2019-04-21 ·...
Documents
differences in the glucose-lowering efficacy of dipeptidyl...
Documents
comparison of efficacy between different incretin based ......
Documents
comorbidities in cerebr
Documents
should dipeptidyl peptidase-4 (dpp-4) inhibitors be
Documents
dipeptidyl peptidase-4 (dpp-4) inhibitors · 2020-05-23 ·...
Documents
a review: dipeptidylpeptidase-4 inhibitors (gliptins) ·...
Documents
the effects of dpp-4 inhibitors on vascular endothelial...
Documents
diabetes workshop: developing strategies for the most...
Documents
the effects of dpp-4 inhibitors on vascular endothelial...
Documents
dipeptidyl peptidase 4 (dpp-4) inhibitors and...
Documents
efficacy and safety of dipeptidyl peptidase-4 inhibitors ·...
Documents
dpp-4 inhibitors as treatments for type 1 diabetes mellitus:...
Documents
the place of dpp-4 inhibitors in the treatment algorithm...
Documents
oral anti-diabetic agents-review and updates€¦ ·...
Documents
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
Health & Medicine
research article renal protective effect of dpp-4...
Documents